LOGIN  |  REGISTER
Amneal Pharmaceuticals
Terns Pharmaceuticals

Varex Imaging Announces Non-Intrusive Cargo Inspection Systems Orders Valued at $25 Million

May 08, 2025 | Last Trade: US$6.88 1.77 -20.46

SALT LAKE CITY / May 08, 2025 / Business Wire / Varex Imaging Corporation (Nasdaq: VREX) today announced that it has received orders for its high-energy non-intrusive cargo and vehicle inspection systems valued at approximately $25 million USD from an international customer. The systems will be placed at strategic locations securing sea and land ports.

Varex Imaging CEO, Sunny Sanyal, stated, “As a leader in high energy Linear Accelerator based imaging, we are pleased to see that our technology, and track record for quality and excellence is enabling us to win new business in Cargo Systems. We are glad to partner with our customers and end users to help secure ports and borders globally.”

For more information about Varex’s non-intrusive cargo inspection systems, please contact your Varex representative or visit our website at https://www.vareximaging.com/security-solutions/.

About Varex

Varex Imaging Corporation is a leading innovator, designer, and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors, and other image processing solutions that are key components of X-ray imaging systems, as well as X-ray imaging systems for industrial applications. With a 70+ year history of successful innovation, Varex’s products are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers incorporate the company’s X-ray sources, digital detectors, connecting devices, and imaging software in their systems to detect, diagnose, protect, and inspect. Headquartered in Salt Lake City, Utah, Varex employs approximately 2,300 people located in North America, Europe, and Asia. For more information visit vareximaging.com.

Forward Looking Statements

This news release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning interest in and adoption and performance of our products and systems; our technology and reputation enabling us to win business; strengthening our portfolio of offerings; and impact on safety and security of infrastructures; and any statements using the terms “expect,” “could,” “may,” “designed,” and “possible” or similar statements are forward-looking statements that involve risks and uncertainties that could cause our actual results and the outcome and timing of certain events to differ materially from those projected or management’s current expectations. Any forward-looking statement made by us in this news release speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. Varex assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.

C4 Therapeutics

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page